Nonpharmacological Interventions for Protection of Myocardial Ischemia-reperfusion Injury among Patient with ST Elevation Myocardial Infarction: A Brief Review

被引:0
作者
Jangra, Mandeep Kumar [1 ]
Mirza, Mehroz Ahmed [3 ]
Goyal, Manu [2 ]
机构
[1] Maharishi Markandeshwar Inst Physiotherapy & Rehab, Dept Cardiopulm Physiotherapy, Ambala, Haryana, India
[2] Maharishi Markandeshwar Inst Physiotherapy & Rehab, Ambala 133207, Haryana, India
[3] Maharishi Markandeshwar Inst Med Sci & Res, Dept Cardiol, Ambala, Haryana, India
关键词
Acute myocardial infarction; cardioprotection; primary percutaneous coronary intervention; reperfusion injury; PERCUTANEOUS CORONARY INTERVENTION; ADJUNCTIVE THERAPY; SIZE; HYPOTHERMIA; SAFETY;
D O I
10.4103/jpcs.jpcs_2_24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction:Numerous nonpharmacological interventions are being investigated for cardioprotective effects among individuals with acute myocardial infarction (MI) who underwent revascularization. However, results of these trials are contradictory. This review aimed to explore the emerging nonpharmacological interventions to prevent myocardial reperfusion injury (RI).Materials and Methods:This review followed Introduction, Methods, Results, Discussion pattern for nonsystematic reviews. Article published form 2015 to November 2023 were retrieved from PubMed, Science direct, and Scopus. Population, Intervention, Comparator, Outcomes, Study design format was used to assess the eligibility of articles where population was ST elevated MI; Intervention was any nonpharmacological interventions such as ischemic postconditioning, therapeutic hypothermia, low level laser therapy (LLLT), remote ischemic conditioning (RIC), and therapeutic hyperoxemia; Comparator can be placebo/sham or control groups, Outcomes were infarct size and cardiac biomarkers and study design can be randomized clinical trials, pre-post experimental studies, etc.Results:15,889 articles were identified and after duplicate removal and assessing eligibility criteria, 27 articles were included in this review. Out of 27, 7 studies used ischemic post conditioning where only 3 studies revealed improvements in ejection fraction and reduction in cardiac biomarkers; 12 studies employed RIC in which only 2 studies showed improvements in ejection fraction whereas 5 showed reduction in peak cardiac biomarkers, 7 experimental studies used therapeutic hypothermia in which only 1 study showed reduction in infract size postintervention, and one study used LLLT where reduction in cardiac biomarkers was seen postintervention.Conclusion:Ischemic postconditioning and RIC showed significant results on myocardial RI whereas therapeutic hypothermia revealed nonsignificant results in most of the trials and failed to prove its efficacy in preventing Myocardial RI. However, a new intervention LLLT proved to be significantly effective in preventing myocardial RI in one human clinical trial.
引用
收藏
页码:137 / 144
页数:8
相关论文
共 50 条
  • [31] Reperfusion options in ST-elevation myocardial infarction patients with expected delays
    Larson D.M.
    Henry T.D.
    Current Cardiology Reports, 2008, 10 (5) : 415 - 423
  • [32] Aborted myocardial infarction in patients with ST-segment elevation myocardial infarction treated with mechanical reperfusion
    Konarski, Lukasz
    Debinski, Marcin
    Kolarczyk-Haczyk, Aleksandra
    Jelonek, Michal
    Kondys, Marek
    Buszman, Pawel
    KARDIOLOGIA POLSKA, 2021, 79 (01) : 39 - 45
  • [33] Reperfusion strategies for ST-elevation myocardial infarction
    Shah S.R.
    Hochberg C.P.
    Pinto D.S.
    Gibson C.M.
    Current Cardiology Reports, 2007, 9 (4) : 281 - 288
  • [34] Contemporary pharmacological reperfusion in ST elevation myocardial infarction
    Welsh, Robert C.
    Armstrong, Paul W.
    CURRENT OPINION IN CARDIOLOGY, 2012, 27 (04) : 340 - 346
  • [35] Protective Biomolecular Mechanisms of Glutathione Sodium Salt in Ischemia-Reperfusion Injury in Patients with Acute Coronary Syndrome-ST-Elevation Myocardial Infarction
    Arrivi, Alessio
    Barilla, Francesco
    Carnevale, Roberto
    Sordi, Martina
    Pucci, Giacomo
    Tanzilli, Gaetano
    Prandi, Francesca Romana
    Mangieri, Enrico
    CELLS, 2022, 11 (24)
  • [36] Protective Effects of Tirofiban on Myocardial Ischemia-Reperfusion Injury in Rabbits
    Pan, Gang
    Long, Sheng-Chun
    Xu, Xi-Ping
    Zhao, Jian-Hua
    Li, Zheng-Zai
    Zhang, Xu-Bin
    Lu, Yong-Hua
    Zhang, Zhi-Wei
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (06) : E1427 - E1435
  • [37] Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction
    Rout, Amit
    Tantry, Udaya S.
    Novakovic, Marko
    Sukhi, Ajaypaul
    Gurbel, Paul A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (15) : 1851 - 1865
  • [38] Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis
    Basnet, Suresh
    Kozikowski, Andrzej
    Makaryus, Amgad N.
    Pekmezaris, Renee
    Zeltser, Roman
    Akerman, Meredith
    Lesser, Martin
    Wolf-Klein, Gisele
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (10):
  • [39] Myocardial ischemia-reperfusion injury: a neglected therapeutic target
    Hausenloy, Derek J.
    Yellon, Derek M.
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (01) : 92 - 100
  • [40] Arginase as a target for treatment of myocardial ischemia-reperfusion injury
    Tratsiakovich, Yahor
    Yang, Jiangning
    Gonon, Adrian Thomas
    Sjoquist, Per-Ove
    Pernow, John
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 720 (1-3) : 121 - 123